An intraocular lens implant, or IOL, is made of clear plastic, and it functions as an artificial standby for the defected eye lens. It is one of the component of the surgery for fixing cataracts through the process of refractive lens exchange. Many eye surgeons prescribe correction glasses after the surgery to fix the short- or long-sightedness caused by the implanted lens.

In 2018, a large chunk of the market share was held by the North America regional market in the global intraocular lens market when segmented by geography. North America region had backed almost XX% of the market share by the base year 2018 and is expected to continue contributing a significant portion of the share by approximately XX% in 2027 as compared to 2018. The market in North America is expected to advance at 4.37% CAGR by the end of the forecasting years.

North America accounted for the largest market share in 2018, owing to the rising geriatric population suffering from various ocular diseases. The prevalence of blindness and vision impairment and other eye-related disorders is expected to increase rapidly among all age group, gender and racial group in North America. However, few factors such as high market saturation, economic slowdown, drying pipelines and increasing competition are some of the factors hampering the potential of the North America intraocular lens market. The United States and Canada are considered for the market analysis.

The number of cataract procedures performed in inpatient settings or hospitals has reduced slightly over the years in the region. The decrease can be attributable to the high cost and increased length of stay in hospitals. Even with the certain reduction in the implantation surgery rate, hospitals generate immense amounts of revenue for the market mainly since the geriatric population makes up its patient pool, where their surgeries take place in the hospitals.

Eyekon Medical Inc., Alcon, Hoya Corporation, Lenstec, Inc., Rayner Intraocular Lenses Ltd., Staar Surgical Company, Santen Pharmaceutical Co., Ltd., Pfizer, Carl Zeiss AG, HumanOptics AG, Abbott Medical Optics, Inc. (subsidiary of Abbott Laboratories, Inc.), Bausch Health Companies Inc. (formerly Valent Pharmaceuticals International Inc.), Johnson & Johnson, Inc., and Essilor International S.A. are the major market players that are involved in the intraocular lens market. All these companies try to satisfy new customers and to fulfil their fast shifting requirements. These companies also aim at business expansions and entering into partnership agreements to gain a competitive advantage.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.